Every doctor's visit, laboratory result, scan, biopsy and treatment becomes part of your medical history. For most patients, these records feel like documentation of what has already happened. But when standard treatment options become limited, they can serve another purpose:
Your medical records become the data used to determine what might still be possible.
A diagnosis alone is rarely enough to identify an advanced treatment or clinical trial. Researchers may need to know your exact pathology, previous treatments, laboratory values, disease progression, molecular profile and dozens of other details.
In modern medicine, the difference between finding a potential option and missing it can sometimes come down to what is documented in your record.
Medicine Has Become Data-Driven
The scale of this transformation is remarkable. By 2024, more than 99% of U.S. non-federal acute care hospitals used certified electronic health record (EHR) technology, compared with fewer than 10% in 2008, according to the U.S. Office of the National Coordinator for Health Information Technology. Among office-based physicians, electronic health record adoption has also become widespread.
This shift matters because medical information can increasingly be searched, compared and analyzed rather than simply stored. For patients looking for advanced treatment, that has enormous implications.
Your Medical Record Is Also an Eligibility Profile
Clinical trials do not enroll patients based only on diagnosis. Protocols may specify dozens of requirements involving:
- previous treatments
- disease stage and progression
- laboratory values
- organ function
- biomarkers and mutations
- other medical conditions
- medications
- previous procedures
An analysis of electronic health records from 355 patients with non-small cell lung or colorectal cancer found that AI-assisted review improved the accuracy of clinical trial prescreening from 71.1% to 76.5%, with the greatest improvements seen in evaluating biomarker, disease staging, and treatment-response criteria.
This highlights an important distinction. Your diagnosis may identify which trials are worth exploring. But the details in your medical records can determine whether you actually qualify.
Missing Information Can Mean a Missed Opportunity
Imagine a clinical trial requiring a specific mutation, but the molecular report cannot be located. Or a protocol excludes patients previously treated with a particular drug, but the treatment history is incomplete. Or eligibility depends on recent laboratory values that are missing.
The trial may be potentially relevant, but the information needed to establish eligibility is not available. This is increasingly important because clinical trial matching is beginning to move from manual chart review toward automated analysis of electronic health records.
A 2024 Scientific Reports study developed an automated system for matching patient records against trial eligibility criteria and reported an F1 score of 0.94, showing how accurately structured medical data can potentially support trial screening.
The technology is getting better. But even the best matching system cannot find information that was never recorded, tested or made available.
One Biomarker Result Can Change the Search
This is especially important in oncology. Two people may have the same cancer diagnosis but very different molecular characteristics — and therefore very different treatment possibilities. Biomarker testing can help identify treatments that may work for a particular cancer and can also help patients find clinical trials evaluating therapies directed at specific biomarkers. A biomarker report may therefore reveal a treatment opportunity that is invisible from the diagnosis alone.
And there is another important point: cancer can change over time. Biomarker testing represents a snapshot of the cancer at a particular moment, meaning earlier results may not always reflect the disease after recurrence or progression.
That is why the question is not simply:
“Have I ever had biomarker testing?”
It may also be:
“Do my existing results still tell us what we need to know today?”
What Patients Should Have Ready
When exploring a second opinion, clinical trial or experimental treatment, patients should ideally be able to provide a clear medical history including:
- pathology and biopsy reports
- imaging reports and relevant scans
- complete treatment history, including drug names and dates
- surgery and radiation history
- recent laboratory results
- molecular, genomic and biomarker testing
- documentation of treatment response and progression
This does not mean collecting every piece of paper generated during years of medical care.
The goal is to create a clear clinical picture that another medical team can understand quickly and accurately.
Your Records Are About the Future, Not Just the Past
Healthcare has already undergone a massive transition from paper records to digital data. Now the next transformation is underway: using that data to identify patients, match them to research and make clinical development more precise.
For an individual patient, however, the implication is much more personal.
- A pathology report can refine a diagnosis.
- A treatment history can determine clinical trial eligibility.
- A laboratory result can exclude or qualify a patient.
- A biomarker result can reveal an entirely different treatment pathway.
Right2Hope Perspective
At Right2Hope, medical records are central to the search for additional treatment possibilities.
When a patient comes to us after standard options have become limited, we look beyond the diagnosis. The details contained in their medical history can help identify potentially relevant clinical trials, biomarker-driven opportunities and other experimental treatment pathways that may deserve further discussion with their medical team.
Because your medical records are not simply a history of what medicine has already done for you. They are also data that may help determine what medicine can offer you next.